Phenethyl isothiocyanate upregulates death receptors 4 and 5 and inhibits proliferation in human cancer stem-like cells

BMC Cancer

Volumn 14, Issue 1, 2014, Pages

  Wang, Dan ^a   Upadhyaya, Bijaya ^a   Liu, Yi ^a   Knudsen, David ^a   Dey, Moul ^a  

^a SOUTH DAKOTA STATE UNIVERSITY   (United States)

Author keywords

Apoptosis; Cancer stem cells; Death receptors; Phenethyl isothiocyanate; TRAIL

Indexed keywords

DEATH RECEPTOR 4; DEATH RECEPTOR 5; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PACLITAXEL; PHENETHYL ISOTHIOCYANATE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; ANTINEOPLASTIC AGENT; ISOTHIOCYANIC ACID DERIVATIVE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER STEM CELL; CARCINOGENICITY; CELL PROLIFERATION; CONTROLLED STUDY; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HELA CELL LINE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG METASTASIS; MITOSIS INHIBITION; MOUSE; NONHUMAN; SIGNAL TRANSDUCTION; UTERINE CERVIX CANCER; WESTERN BLOTTING; XENOTRANSPLANTATION; ANIMAL; CULTURE TECHNIQUE; DRUG EFFECTS; DRUG SCREENING; LUNG NEOPLASMS; METABOLISM; NONOBESE DIABETIC MOUSE; PATHOLOGY; SCID MOUSE; SECONDARY;

ANIMALS; ANTICARCINOGENIC AGENTS; APOPTOSIS; CELL CULTURE TECHNIQUES; CELL PROLIFERATION; HELA CELLS; HUMANS; ISOTHIOCYANATES; LUNG NEOPLASMS; MICE; MICE, INBRED NOD; MICE, SCID; NEOPLASTIC STEM CELLS; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84908377660     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-14-591     Document Type: Article

References (45)

1. Liu MT, Huang WT, Wang AY, Huang CC, Huang CY, Chang TH, Pi CP, Yang HH: Prediction of outcome of patients with metastatic breast cancer: evaluation with prognostic factors and Nottingham prognostic index. Support Care Cancer 2010, 18(12):1553-1564.
2. Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, Jones DL, Visvader J, Weissman IL, Wahl GM: Cancer stem cells-perspectives on current status and future directions: AACR workshop on cancer stem cells. Cancer Res 2006, 66(19):9339-9344.
3. Chen K, Huang YH, Chen JL: Understanding and targeting cancer stem cells: therapeutic implications and challenges. Acta Pharmacol Sin 2013, 34(6):732-740.
4. Reya T, Morrison SJ, Clarke MF, Weissman IL: Stem cells, cancer, and cancer stem cells. Nature 2001, 414(6859):105-111.
5. Gu W, Yeo E, McMillan N, Yu C: Silencing oncogene expression in cervical cancer stem-like cells inhibits their cell growth and self-renewal ability. Cancer Gene Ther 2011, 18(12):897-905.
6. Fenwick GR, Heaney RK, Mullin WJ: Glucosinolates and their breakdown products in food and food plants. Crit Rev Food Sci Nutr 1983, 18(2):123-201.
7. Dey M, Ripoll C, Pouleva R, Dorn R, Aranovich I, Zaurov D, Kurmukov A, Eliseyeva M, Belolipov I, Akimaliev A, Sodombekov I, Akimaliev D, Lila MA, Raskin I: Plant extracts from central Asia showing antiinflammatory activities in gene expression assays. Phytother Res 2008, 22(7):929-934.
8. Dey M, Kuhn P, Ribnicky D, Premkumar V, Reuhl K, Raskin I: Dietary phenethylisothiocyanate attenuates bowel inflammation in mice. BMC Chem Biol 2010, 10:4.
9. Liu Y, Chakravarty S, Dey M: Phenethylisothiocyanate alters site-and promoter-specific histone tail modifications in cancer cells. PLoS One 2013, 8(5):e64535.
10. Mukherjee S, Bhattacharya RK, Roy M: Targeting protein kinase C (PKC) and telomerase by phenethyl isothiocyanate (PEITC) sensitizes PC-3 cells towards chemotherapeutic drug-induced apoptosis. J Environ Pathol Toxicol Oncol 2009, 28(4):269-282.
11. Kang L, Wang ZY: Breast cancer cell growth inhibition by phenethyl isothiocyanate is associated with down-regulation of oestrogen receptor-alpha36. J Cell Mol Med 2010, 14(6B):1485-1493.
12. le Huong D, Shim JH, Choi KH, Shin JA, Choi ES, Kim HS, Lee SJ, Kim SJ, Cho NP, Cho SD: Effect of beta-phenylethyl isothiocyanate from cruciferous vegetables on growth inhibition and apoptosis of cervical cancer cells through the induction of death receptors 4 and 5. J Agric Food Chem2011, 59(15):8124-8131.
13. Wang X, Govind S, Sajankila SP, Mi L, Roy R, Chung FL: Phenethyl isothiocyanate sensitizes human cervical cancer cells to apoptosis induced by cisplatin. Mol Nutr Food Res 2011, 55(10):1572-1581.
14. Satyan KS, Swamy N, Dizon DS, Singh R, Granai CO, Brard L: Phenethyl isothiocyanate (PEITC) inhibits growth of ovarian cancer cells by inducing apoptosis: role of caspase and MAPK activation. Gynecol Oncol 2006, 103(1):261-270.
15. Nishikawa A, Furukawa F, Lee IS, Tanaka T, Hirose M: Potent chemopreventive agents against pancreatic cancer. Curr Cancer Drug Targets 2004, 4(4):373-384.
16. NCI: Clinical development plan: phenethyl isothiocyanate. J Cell Biochem Suppl 1996, 26:149-157.
17. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010, 127(12):2893-2917.
18. Lowe SW, Lin AW: Apoptosis in cancer. Carcinogenesis 2000, 21(3):485-495.
19. Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl JK, Sutherland GR, Smith TD, Rauch C, Smith CA, Goodwin RG: Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 1995, 3(6):673-682.
20. Walczak H, Miller RE, Ariail K, Gliniak B, Griffith TS, Kubin M, Chin W, Jones J, Woodward A, Le T, Smith C, Smolak P, Goodwin RG, Rauch CT, Schuh JC, Lynch DH: Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med 1999, 5(2):157-163.
21. Falschlehner C, Emmerich CH, Gerlach B, Walczak H: TRAIL signalling: decisions between life and death. Int J Biochem Cell Biol 2007, 39(7-8):1462-1475.
22. Soldani C, Scovassi AI: Poly(ADP-ribose) polymerase-1 cleavage during apoptosis: an update. Apoptosis 2002, 7(4):321-328.
23. Koschny R, Walczak H, Ganten TM: The promise of TRAIL-potential and risks of a novel anticancer therapy. J Mol Med (Berl) 2007, 85(9):923-935.
24. Nimmanapalli R, Perkins CL, Orlando M, O'Bryan E, Nguyen D, Bhalla KN: Pretreatment with paclitaxel enhances apo-2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of prostate cancer cells by inducing death receptors 4 and 5 protein levels. Cancer Res 2001, 61(2):759-763.
25. Naka T, Sugamura K, Hylander BL, Widmer MB, Rustum YM, Repasky EA: Effects of tumor necrosis factor-related apoptosis-inducing ligand alone and in combination with chemotherapeutic agents on patients' colon tumors grown in SCID mice. Cancer Res 2002, 62(20):5800-5806.
26. Yin S, Xu L, Bandyopadhyay S, Sethi S, Reddy KB: Cisplatin and TRAIL enhance breast cancer stem cell death. Int J Oncol 2011, 39(4):891-898.
27. Wicker CA, Sahu RP, Kulkarni-Datar K, Srivastava SK, Brown TL: BITC sensitizes pancreatic adenocarcinomas to TRAIL-induced apoptosis. Cancer Growth Metastasis 2010, 2009(2):45-55.
28. Kim H, Kim EH, Eom YW, Kim WH, Kwon TK, Lee SJ, Choi KS: Sulforaphane sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-resistant hepatoma cells to TRAIL-induced apoptosis through reactive oxygen species-mediated up-regulation of DR5. Cancer Res 2006, 66(3):1740-1750.
29. Matsui TA, Sowa Y, Yoshida T, Murata H, Horinaka M, Wakada M, Nakanishi R, Sakabe T, Kubo T, Sakai T: Sulforaphane enhances TRAIL-induced apoptosis through the induction of DR5 expression in human osteosarcoma cells. Carcinogenesis 2006, 27(9):1768-1777.
30. Liebes L, Conaway CC, Hochster H, Mendoza S, Hecht SS, Crowell J, Chung FL: High-performance liquid chromatography-based determination of total isothiocyanate levels in human plasma: application to studies with 2-phenethyl isothiocyanate. Anal Biochem 2001, 291(2):279-289.
31. Gupta PB, Onder TT, Jiang G, Tao K, Kuperwasser C, Weinberg RA, Lander ES: Identification of selective inhibitors of cancer stem cells by highthroughput screening. Cell 2009, 138(4):645-659.
32. Scharenberg CW, Harkey MA, Torok-Storb B: The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors. Blood 2002, 99(2):507-512.
33. Luna LG: Routine staining procedure. In Manual of Histologic staining methods of the armed forces. 3rd edition. Edited by Luna LG. New York: McGraw-Hill Book Company, Blakiston Division; 1968:32-39.
34. Jordan MA, Wendell K, Gardiner S, Derry WB, Copp H, Wilson L: Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death. Cancer Res 1996, 56(4):816-825.
35. Angioli R, Luvero D, Aloisi A, Capriglione S, Gennari P, Linciano F, Li Destri M, Scaletta G, Montera R, Plotti F: Adjuvant chemotherapy after primary treatments for cervical cancer: a critical point of view and review of the literature. Expert Rev Anticancer Ther 2014, 14(4):431-439.
36. Richardson MA: Biopharmacologic and herbal therapies for cancer: research update from NCCAM. J Nutr 2001, 131(11 Suppl):3037S-3040S.
37. Naujokat C, Steinhart R: Salinomycin as a drug for targeting human cancer stem cells. J Biomed Biotechnol 2012, 2012:950658.
38. Li M, Knight DA, Smyth MJ, Stewart TJ: Sensitivity of a novel model of mammary cancer stem cell-like cells to TNF-related death pathways. Cancer Immunol Immunother 2012, 61(8):1255-1268.
39. Sheridan JP, Marsters SA, Pitti RM, Gurney A, Skubatch M, Baldwin D, Ramakrishnan L, Gray CL, Baker K, Wood WI, Goddard AD, Godowski P, Ashkenazi A: Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science 1997, 277(5327):818-821.
40. Johnstone RW, Frew AJ, Smyth MJ: The TRAIL apoptotic pathway in cancer onset, progression and therapy. Nat Rev Cancer 2008, 8(10):782-798.
41. Rushworth SA, Micheau O: Molecular crosstalk between TRAIL and natural antioxidants in the treatment of cancer. Br J Pharmacol 2009, 157(7):1186-1188.
42. Yu R, Mandlekar S, Harvey KJ, Ucker DS, Kong AN: Chemopreventive isothiocyanates induce apoptosis and caspase-3-like protease activity. Cancer Res 1998, 58(3):402-408.
43. Dey M, Ribnicky D, Kurmukov AG, Raskin I: In vitro and in vivo anti-inflammatory activity of a seed preparation containing phenethylisothiocyanate. J Pharmacol Exp Ther 2006, 317(1):326-333.
44. Fiers W: Tumor necrosis factor. Characterization at the molecular, cellular and in vivo level. FEBS Lett 1991, 285(2):199-212.
45. Kim K, Fisher MJ, Xu SQ, el-Deiry WS: Molecular determinants of response to TRAIL in killing of normal and cancer cells. Clin Cancer Res 2000, 6(2):335-346.